Sullivan, Bruyette, Speros & Blaney’s Cigna CI Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$781K	Buy	3,231 +595	+23%	+$133K	0.03%	137
2020 Q4	$549K	Sell	2,636 -106	-4%	-$20.8K	0.03%	157
2020 Q3	$465K	Buy	2,742 +1,200	+78%	+$211K	0.03%	157
2020 Q2	$289K	Sell	1,542 -88	-5%	-$16.7K	0.02%	188
2020 Q1	$289K	Sell	1,630 -12	-0.7%	-$2.33K	0.02%	172
2019 Q4	$336K	Sell	1,642 -210	-11%	-$38.5K	0.02%	178
2019 Q3	$281K	Sell	1,852 -75	-4%	-$12.2K	0.02%	193
2019 Q2	$304K	Buy	1,927 +23	+1%	+$3.6K	0.02%	178
2019 Q1	$306K	Buy	1,904 +243	+15%	+$44.4K	0.02%	162
2018 Q4	$315K	Buy	+1,661	New	+$347K	0.02%	148

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's CI Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its Cigna (CI) stake by 23% in Q1 2021, buying an estimated $133K and bringing the position to 3,231 shares worth $781K. The position accounts for 0.03% of the portfolio, ranked #137.

Sullivan, Bruyette, Speros & Blaney first reported a position in CI in Q4 2018 and has held it in 10 quarters since. 1,248 funds tracked by Wall St. Rank hold CI as of Q1 2021.

Sullivan, Bruyette, Speros & Blaney held 3,231 shares of Cigna worth $781K as of Q1 2021.
Sullivan, Bruyette, Speros & Blaney bought 595 Cigna shares in Q1 2021, an estimated $133K.
Cigna made up 0.03% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #137 holding.
Sullivan, Bruyette, Speros & Blaney first reported a position in Cigna in Q4 2018 and has held it in 10 quarters since.
1,248 funds tracked by Wall St. Rank held Cigna as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.